Hydrix to sell AI technology that improves identification of structural heart disease
Hydrix Limited (ASX: HYD) (Hydrix or the Company) is pleased to announce that it has entered into a commercial agreement…
We develop extraordinary products and technologies for global clients.
Hydrix Medical is committed to bringing and distributing cardiac technology to market.
This is our vision. It’s a bold challenge that motivates our team on a daily basis.
We are building on our rich product innovation history to develop, invest in, and commercialise novel cardiovascular devices and technologies to create long-term value.
Our latest news and articles from Hydrix, including announcements, awards and industry news. Read more